NanoViricides Inc. (NNVC)

[JG36]

This is the first hint I've seen that NNVC intends to use the new manufacturing facility to create the Flucide used in the tox studies. It's nice for management to let us know, as this obviously has a major impact on the scheduling. (Instead of being done in parallel with the construction and testing of the manufacturing facility, tox must now be done after that.) This easily adds about 7 months to any previous estimate of when clinical trials can begin.

As for the delays not being under NNVC management's control, well duh. In any project like this you have to allow ample slack in the schedule for the inevitable delays that you can't control.